Frontiers in Cardiovascular Medicine | Cardiovascular Pharmacology and Drug Discovery

Original Research

Published on 13 May 2024

A real-world pharmacovigilance study of drug-induced QT interval prolongation: analysis of spontaneous reports submitted to FAERS

in Cardiovascular Pharmacology and Drug Discovery

Haowen Tan
Xida Yan
Ying Chen
Guili Huang
Luping Luo
Wenjun Li
Weiwei Lan
Cheng Chen
Xin Xi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1363382

3,353 views
1 citation

Review

Published on 09 May 2024

The role of lymphatic endothelial cell metabolism in lymphangiogenesis and disease

in Cardiovascular Pharmacology and Drug Discovery

Summer Simeroth
Pengchun Yu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1392816

3,111 views
1 citation

Original Research

Published on 25 Apr 2024

SGLT2 inhibition, plasma proteins, and heart failure: a proteome-wide Mendelian Randomization and colocalization study

in Cardiovascular Pharmacology and Drug Discovery

Jinlan Luo
Lili Shi
Jingrui Liu
Gen Li
Ling Tu
Shuiqing Hu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1371513

3,957 views

Review

Published on 23 Apr 2024

Clinical evidence and potential mechanisms of traditional Chinese medicine for refractory heart failure: a literature review and perspectives

in Cardiovascular Pharmacology and Drug Discovery

Liuli Guo
Zhihua Yang
Wenshuai Feng
Yiman Liu
Zhenzhen Li
Pengwei Zhuang
Ming Ren

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1369642

1,590 views

Review

Published on 18 Apr 2024

Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation

in Cardiovascular Pharmacology and Drug Discovery

Yan Zhang
Xue-Ying Zhang
Shan-Rui Shi
Chao-Nan Ma
Yun-Peng Lin
Wen-Gang Song
Shou-Dong Guo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1372055

3,497 views
7 citations

Review

Published on 19 Mar 2024

Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future

in Cardiovascular Pharmacology and Drug Discovery

Shujing Zhou
Ying Liu
Xufeng Huang
Chuhan Wu
Róbert Pórszász

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1337154

9,239 views
2 citations

Mini Review

Published on 13 Mar 2024

Effect of statin add-on therapy on cardiovascular mortality

in Cardiovascular Pharmacology and Drug Discovery

John R. Nelson
Viet Le
Jeffrey L. Anderson
Nicole Ciffone

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1308695

3,260 views

Review

Published on 01 Mar 2024

Silicon in prevention of atherosclerosis and other age-related diseases

in Cardiovascular Pharmacology and Drug Discovery

Łukasz Dudek
Wacław Kochman
Ewelina Dziedzic

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1370536

8,186 views
2 citations

Review

Published on 23 Feb 2024

Data sources and applied methods for paclitaxel safety signal discernment

in Cardiovascular Pharmacology and Drug Discovery

Laura Elisabeth Gressler
Erika Avila-Tang
Jialin Mao
Alejandra Avalos-Pacheco
Fadia T. Shaya
Yelizaveta Torosyan
Alexander Liebeskind
Madris Kinard
Christina D. Mack
Sharon-Lise Normand

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1331142

2,525 views

Original Research

Published on 14 Feb 2024

Anti-hypertensive effect of a novel angiotensin II receptor neprilysin inhibitor (ARNi) -S086 in DSS rat model

in Cardiovascular Pharmacology and Drug Discovery

Jingchao Sun
Ying Xiao
Wenjie Xu
Wei Xing
Frank Du
Maozhi Tian
Danqi Xu
Yihua Ren
Xin Fang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1348897

3,273 views
2 citations

Systematic Review

Published on 13 Feb 2024

Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis

in Cardiovascular Pharmacology and Drug Discovery

Liuying Li
Peimin Feng
Wenhua Zhou
Biao Luo
Lvyu Deng
Daohui Gan
Xiaohan Wu
Fengya Zhu
Xia Zhou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1229299

2,354 views
1 citation

Review

Published on 15 Jan 2024

Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins

in Cardiovascular Pharmacology and Drug Discovery

K. Vijayaraghavan
S. Baum
N. R. Desai
S. J. Voyce

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1308173

2,721 views

Editorial

Published on 15 Jan 2024

Editorial: New and emerging lipid-lowering therapies for reducing cardiovascular risk: beyond statins

in Cardiovascular Pharmacology and Drug Discovery

Fei Luo
Liqing Yu
Xunde Xian
Bo Shan
Avash Das

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1364170

2,357 views

Study Protocol

Published on 08 Jan 2024

Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial

in Cardiovascular Pharmacology and Drug Discovery

Yulin Leng
Zehua Zhang
Nairong Yao
Xiaoxu Fu
Hongyan Xie
Hong Gao
Chunguang Xie

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1290240

2,616 views

Study Protocol

Published on 03 Jan 2024

The effect of pituitrin on postoperative outcomes in patients with pulmonary hypertension undergoing cardiac surgery: a study protocol for a randomized controlled trial

in Cardiovascular Pharmacology and Drug Discovery

Lingchen Kong
Meng Lv
Chang-long Qiao
Xia-xuan Sun
Wen-ya Du
Quan Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1269624

2,102 views

Original Research

Published on 21 Dec 2023

Comparison of esketamine versus dexmedetomidine for attenuation of cardiovascular stress response to double-lumen tracheal tube intubation: a randomized controlled trial

in Cardiovascular Pharmacology and Drug Discovery

Chunyu Liu
Tianhua Zhang
Longhui Cao
Wenqian Lin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1289841

2,491 views
2 citations